Drug Profile
Tocilizumab biosimilar - BioGen/Bio-Thera Solutions
Alternative Names: BAT-1806; BIIB-800; Tocilizumab-bavi; TOFIDENCELatest Information Update: 21 Feb 2024
Price :
$50
*
At a glance
- Originator Bio-Thera Solutions
- Developer Bio-Thera Solutions; Biogen
- Class Anti-inflammatories; Antineoplastics; Antirheumatics; Immunotherapies; Monoclonal antibodies; Skin disorder therapies; Vascular disorder therapies
- Mechanism of Action Interleukin 6 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Cytokine release syndrome; Juvenile rheumatoid arthritis; Rheumatoid arthritis
- Phase III Giant cell arteritis